NCT00092144View on ClinicalTrials.gov

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 26, 2004

Primary Completion Date

June 15, 2004

Study Completion Date

June 15, 2004

Conditions
Asthma
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment: 4 weeks

DRUG

Comparator: placebo / Duration of Treatment: 4 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092144 - Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED) | Biotech Hunter | Biotech Hunter